Pretreatment NPLH as a Potential Predictor of Pathologic Complete Response to Accelerated MVAC Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Comparison with NLR and PLR.

Cancers (Basel) · 2026 · PMC13359953 · PMID 42449592

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Comparison with NLR and PLR NPLH was numerically superior to NLR (AUC 0.645) and PLR (AUC 0.643) for pCR prediction ( Table 3 ); however, the difference did not reach statistical significance on formal DeLong test: NPLH vs.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.